Cargando…
Prevalence of neuroleptic malignant syndrome in 672 consecutive male in-patients
BACKGROUND: Neuroleptic malignant syndrome (NMS) is the most serious and potentially fatal adverse effect of neuroleptic medications. Although it occurs most frequently with conventional antipsychotic medicines, it may occur with newer antipsychotic medicines also. So far, there is no study availabl...
Autores principales: | Sarkar, Pradyot, Natarajan, Chandrashekhar, Gode, Neeta |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772217/ https://www.ncbi.nlm.nih.gov/pubmed/19881049 http://dx.doi.org/10.4103/0019-5545.55089 |
Ejemplares similares
-
NEUROLEPTIC MALIGNANT SYNDROME
por: Jayesh, Kanabar
Publicado: (1997) -
Neuroleptic malignant syndrome
por: Rajamani, Bino, et al.
Publicado: (2016) -
Neuroleptic malignant syndrome
por: Tan, Carolyn Michelle, et al.
Publicado: (2023) -
Risk Factors in Neuroleptic Malignant Syndrome
por: Gupta, Vinay, et al.
Publicado: (2003) -
INCREASED RISK OF OCCURRENCE OF NEUROLEPTIC MALIGNANT SYNDROME ON COMBINED TREATMENT WITH LITHIUM AND NEUROLEPTIC
por: Alexander, P. John, et al.
Publicado: (1997)